0001601830-24-000022.txt : 20240308
0001601830-24-000022.hdr.sgml : 20240308
20240308190851
ACCESSION NUMBER: 0001601830-24-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibson Christopher
CENTRAL INDEX KEY: 0001856369
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40323
FILM NUMBER: 24736167
MAIL ADDRESS:
STREET 1: C/O RECURSION PHARMACEUTICALS
STREET 2: 41 S. RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001601830
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464099738
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
BUSINESS PHONE: (385) 269-0203
MAIL ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
FORMER COMPANY:
FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20140305
4
1
wk-form4_1709942921.xml
FORM 4
X0508
4
2024-03-06
0
0001601830
RECURSION PHARMACEUTICALS, INC.
RXRX
0001856369
Gibson Christopher
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET
SALT LAKE CITY
UT
84101
1
1
0
0
Chief Executive Officer
0
Class A Common Stock
2024-03-06
4
C
0
10000
0
A
1114919
D
Class A Common Stock
2024-03-06
4
G
0
10000
0
D
1104919
D
Class A Common Stock
2024-03-06
4
M
0
31250
2.48
A
1136169
D
Class A Common Stock
2024-03-06
4
M
0
8674
11.40
A
1144843
D
Class A Common Stock
2024-03-06
4
S
0
36319
11.8583
D
1108524
D
Class A Common Stock
2024-03-06
4
C
0
4000
0
A
4000
I
by LAHWRAN-3 LLC
Class A Common Stock
2024-03-06
4
S
0
4000
11.5648
D
0
I
by LAHWRAN-3 LLC
Class A Common Stock
2024-03-06
4
C
0
20000
0
A
20000
I
By LAHWRAN-4 LLC
Class A Common Stock
2024-03-06
4
S
0
20000
11.5501
D
0
I
By LAHWRAN-4 LLC
Class A Common Stock
2024-03-06
4
C
0
1000
0
A
1000
I
by Gibson Family Trust
Class A Common Stock
2024-03-06
4
S
0
1000
11.5621
D
0
I
by Gibson Family Trust
Stock Option (Right to Buy)
2.48
2024-03-06
4
M
0
31250
0
D
2030-12-30
Class A Common Stock
31250
312500
D
Stock Option (Right to Buy)
11.40
2024-03-06
4
M
0
8674
0
D
2032-02-04
Class A Common Stock
8674
399002
D
Class B Common Stock
0
2024-03-06
4
C
0
10000
0
D
Class A Common Stock
10000
6461496
D
Class B Common Stock
0
2024-03-06
4
C
0
4000
0
D
Class A Common Stock
4000
511000
I
by LAHWRAN-3 LLC
Class B Common Stock
0
2024-03-06
4
C
0
20000
0
D
Class A Common Stock
20000
388000
I
by LAHWRAN-4 LLC
Class B Common Stock
0
2024-03-06
4
C
0
1000
0
D
Class A Common Stock
1000
117875
I
by Gibson Family Trust
Stock Option (Right to Buy)
8.55
2033-02-01
Class A Common Stock
0
813600
D
Stock Option (Right to Buy)
11.40
2022-02-04
2032-02-04
Class A Common Stock
0
5436
D
Stock Option (Right to Buy)
10.09
2034-02-09
Class A Common Stock
0
666898
D
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $11.24 to $12.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Represents the conversion of Class B Common Stock into Class A Common Stock.
The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
This transaction was executed in multiple trades at prices ranging from $11.32 to $12.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
This transaction was executed in multiple trades at prices ranging from $11.22 to $12.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
This transaction was executed in multiple trades at prices ranging from $11.23 to $12.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
/s/ Jonathan Golightly, attorney-in-fact
2024-03-08